FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2750871225> ?p ?o ?g. }

• W2750871225 endingPage "4265" @default.
• W2750871225 startingPage "4265" @default.
• W2750871225 abstract "Abstract Introduction: Several studies have evaluated the incidence and clinical relevance of cytogenetic abnormalities in primary myelofibrosis (PMF). However, little is known about the clinical correlation of these abnormalities in patients with post-essential thrombocythemia/polycythemia vera myelofibrosis (PET/PPV-MF). Objective: We aimed to measure the frequency of cytogenetic abnormalities (Abn) and describe their clinical significance in patients with PMF and PET/PPV-MF seen at our center. Methods: We retrospectively reviewed the charts of 1100 patients with MF (766 PMF, 354 PET/PV-MF) who were referred to our institution between 1984 and 2013. Diagnoses were made according to 2008 WHO criteria. Cytogenetic analysis done at the time of referral was reported according to the International System for Human Cytogenetic Nomenclature. Statistical analysis considered parameters at the time of cytogenetic studies. Complex karyotype (CK) was defined as 3 or more unrelated abnormalities (Abn) and monosomal karyotype (MK) was defined as 2 autosomal monosomies or a single monosomy with at least one additional structural abnormality. Fisher's exact, Kruskal-Wallis and Mann-Whitney tests were used for comparisons of categorical and continuous variables, respectively. The Kaplan-Meier analysis with log rank test were used for OS comparisons. Results: Cytogenetic data with > 10 analyzable metaphases were obtained in 981 (89%) patients. Overall, 360 (37%) patients had an abnormal karyotype. Frequency and types of cytogenetic Abn were similar between PMF and PET/PPV-MF (Table 1). Sixty one percent of patients (n=220) had a single Abn, 25% (n=89) had two, and 15% (n=52) had 3 or more Abn, including 6% with MK (n=26). Proportional distribution was similar between PMF and PET/PPV-MF patients. Comparison of patients with one, two, or ≥3 Abn (i.e. CK) revealed that patients with CK were more likely to be anemic (hemoglobin < 10 g/dL, p<0.001) and transfusion dependent (p<0.001) and had higher DIPSS risk scores (p=0.004) than patients with one or two Abn. Among patients with PMF, CK was also associated with thrombocytopenia (p<0.001), while among those with PET/PPV-MF, it was associated with advanced (MF-2, 3) bone marrow fibrosis (p=0.045). Among all patients with one or two Abn, those with Abn in chromosomes 17, 5, or 7 had lower hemoglobin and higher peripheral blood blasts, and were less likely to be JAK2 positive (all p<0.05). Estimated OS was 48 months (range, 43-52) for both patients with PMF and PET/PPV-MF. Among all patients, OS was shorter among those with CK (median 14 months, range 7-21) than in those with one (median 48, range 37-60) or two (median 58, range 43-73) Abn (p=0.000, chi-sq 26.6). Overall median follow up from the time of referral was 29 months (range, 0.5-251) and 61% (n=220) of patients had died. Among all patients, median survival from date of referral was 19 months (range, 0.5-251). During an observation period of 1105 persons-years, progression to AML occurred in 44 (12%) patients after a median time of 13 months (range, 0.5-175). The incidence of AML was higher among those with CK (23% vs 15% vs 13% with CK, two or one Abn, respectively; p=0.014, chi-sq 8.7). Among the known causes of death (in 109 patients), progression of MF/AML was the most common (24%, n=53). Conclusion: The frequency of cytogenetic abnormalities in patients with PMF and PET/PPV-MF and their clinical relevance appear to be similar. Patients with CK have shorter OS and a higher incidence of AML in both PMF and PET/PPV-MF. Table Table. Disclosures Cortes: ARIAD: Consultancy, Research Funding; Bristol-Myers Squib: Consultancy, Research Funding; Novartis: Consultancy, Research Funding; Pfizer: Consultancy, Research Funding; Teva: Research Funding." @default.
• W2750871225 created "2017-09-15" @default.
• W2750871225 creator A5008503600 @default.
• W2750871225 creator A5013173470 @default.
• W2750871225 creator A5015101485 @default.
• W2750871225 creator A5055441745 @default.
• W2750871225 creator A5080350639 @default.
• W2750871225 creator A5085521139 @default.
• W2750871225 creator A5088307376 @default.
• W2750871225 creator A5090435894 @default.
• W2750871225 date "2016-12-02" @default.
• W2750871225 modified "2023-10-15" @default.
• W2750871225 title "Clinical Associations of Cytogenetic Abnormalities in Patients with Primary and Post-Essential Thrombocythemia and Post-Polycythemia Vera Myelofibrosis" @default.
• W2750871225 doi "https://doi.org/10.1182/blood.v128.22.4265.4265" @default.
• W2750871225 hasPublicationYear "2016" @default.
• W2750871225 type Work @default.
• W2750871225 sameAs 2750871225 @default.
• W2750871225 citedByCount "1" @default.
• W2750871225 countsByYear W27508712252021 @default.
• W2750871225 crossrefType "journal-article" @default.
• W2750871225 hasAuthorship W2750871225A5008503600 @default.
• W2750871225 hasAuthorship W2750871225A5013173470 @default.
• W2750871225 hasAuthorship W2750871225A5015101485 @default.
• W2750871225 hasAuthorship W2750871225A5055441745 @default.
• W2750871225 hasAuthorship W2750871225A5080350639 @default.
• W2750871225 hasAuthorship W2750871225A5085521139 @default.
• W2750871225 hasAuthorship W2750871225A5088307376 @default.
• W2750871225 hasAuthorship W2750871225A5090435894 @default.
• W2750871225 hasConcept C104317684 @default.
• W2750871225 hasConcept C126322002 @default.
• W2750871225 hasConcept C142724271 @default.
• W2750871225 hasConcept C191093355 @default.
• W2750871225 hasConcept C2778837598 @default.
• W2750871225 hasConcept C2779142324 @default.
• W2750871225 hasConcept C2780007613 @default.
• W2750871225 hasConcept C2780076729 @default.
• W2750871225 hasConcept C2780189214 @default.
• W2750871225 hasConcept C2781057849 @default.
• W2750871225 hasConcept C30481170 @default.
• W2750871225 hasConcept C53226629 @default.
• W2750871225 hasConcept C55493867 @default.
• W2750871225 hasConcept C63363279 @default.
• W2750871225 hasConcept C71924100 @default.
• W2750871225 hasConcept C86803240 @default.
• W2750871225 hasConcept C90924648 @default.
• W2750871225 hasConceptScore W2750871225C104317684 @default.
• W2750871225 hasConceptScore W2750871225C126322002 @default.
• W2750871225 hasConceptScore W2750871225C142724271 @default.
• W2750871225 hasConceptScore W2750871225C191093355 @default.
• W2750871225 hasConceptScore W2750871225C2778837598 @default.
• W2750871225 hasConceptScore W2750871225C2779142324 @default.
• W2750871225 hasConceptScore W2750871225C2780007613 @default.
• W2750871225 hasConceptScore W2750871225C2780076729 @default.
• W2750871225 hasConceptScore W2750871225C2780189214 @default.
• W2750871225 hasConceptScore W2750871225C2781057849 @default.
• W2750871225 hasConceptScore W2750871225C30481170 @default.
• W2750871225 hasConceptScore W2750871225C53226629 @default.
• W2750871225 hasConceptScore W2750871225C55493867 @default.
• W2750871225 hasConceptScore W2750871225C63363279 @default.
• W2750871225 hasConceptScore W2750871225C71924100 @default.
• W2750871225 hasConceptScore W2750871225C86803240 @default.
• W2750871225 hasConceptScore W2750871225C90924648 @default.
• W2750871225 hasIssue "22" @default.
• W2750871225 hasLocation W27508712251 @default.
• W2750871225 hasOpenAccess W2750871225 @default.
• W2750871225 hasPrimaryLocation W27508712251 @default.
• W2750871225 hasRelatedWork W1986759275 @default.
• W2750871225 hasRelatedWork W2012828222 @default.
• W2750871225 hasRelatedWork W2021432617 @default.
• W2750871225 hasRelatedWork W2094725695 @default.
• W2750871225 hasRelatedWork W2556361229 @default.
• W2750871225 hasRelatedWork W2563770732 @default.
• W2750871225 hasRelatedWork W2586260441 @default.
• W2750871225 hasRelatedWork W2750871225 @default.
• W2750871225 hasRelatedWork W2903749170 @default.
• W2750871225 hasRelatedWork W3197539263 @default.
• W2750871225 hasVolume "128" @default.
• W2750871225 isParatext "false" @default.
• W2750871225 isRetracted "false" @default.
• W2750871225 magId "2750871225" @default.
• W2750871225 workType "article" @default.